- Sage Therapeutics (NASDAQ:SAGE) is scheduled to announce Q2 earnings results on Monday, August 10th, before market open.
- The consensus EPS Estimate is -$2.59 (+21.0% Y/Y) and the consensus Revenue Estimate is $0.88M (+1.1% Y/Y).
- Over the last 2 years, SAGE has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 12 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 11 downward.
Sage Therapeutics Q2 2020 Earnings Preview
Recommended For You
More Trending News
About SAGE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SAGE | - | - |
Sage Therapeutics, Inc. |